Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Dechra Pharmaceuticals    DPH   GB0009633180

DECHRA PHARMACEUTICALS (DPH)
Mes dernières consult.
Most popular
  Report  
Real-time Quote. Real-time Cboe Europe - 07/23 01:05:50 pm
2958 GBp   -1.14%
07/11DECHRA PHARMACE : Revenue increases
AQ
07/10DECHRA PHARMACE : Trading Update and Notice of Preliminary results
PU
07/10DECHRA PHARMACE : Threshold crossings
CO
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on DECHRA PHARMACEUTICALS
09/03/18 FY 2018 Earnings Release - Preliminary
03/04/19 Interim 2019 Earnings Release (Projected)
09/03/19 FY 2019 Earnings Release (Projected)
03/02/20 Interim 2020 Earnings Release (Projected)
Past events on DECHRA PHARMACEUTICALS
03/08/18 Ex-dividend day for interim dividend
02/26/18 | 11:30am Interim 2018 Earnings Call
02/26/18 Interim 2018 Earnings Release
01/25/18 | 09:30am Acquisition of AST Farma B.V. and Le Vet Beheer B.V. by Dechra Pharmaceuticals PLC Call
Upcoming sector events for DECHRA PHARMACEUTICALS
07/24/18 BIOGEN INC : Interim 2018 Earnings Release
07/24/18 | 12:25pm ELI LILLY AND CO : Interim 2018 Earnings Release
07/24/18 | 02:00pm BIOGEN INC : Interim 2018 Earnings Call
07/24/18 | 03:00pm GLAXOSMITHKLINE PLC : International AIDS Conference - GEMINI Results of HIV 2 Drug Regimen
Past sector events for DECHRA PHARMACEUTICALS
07/18/18 | 08:00am SWEDISH ORPHAN BIOVITRUM AB (PUBL) : Interim 2018 Earnings Release
07/18/18 | 02:00pm SWEDISH ORPHAN BIOVITRUM AB (PUBL) : Interim 2018 Earnings Call
07/18/18 | 02:00pm NOVARTIS AG : Interim 2018 Earnings Call
07/19/18 | 02:30pm ALLERGAN PLC : Abicipar CEDAR and SEQUOIA Topline Phase 3 Clinical Study Results Call
Annual publications
Previous yearNext Year
Annual results2015201620172018 (e)2019 (e)
Sales
Million GBP
Released
Forecast
Spread
204
204
-0,03%
248
237
4,5%
359
364
-1,4%

408

462
Operating income (EBITDA)
Million GBP
Released
Forecast
Spread
48,0
48,3
-0,67%
58,0
57,2
1,4%
86,3
88,3
-2,3%

108

134
Operating profit (EBIT)
Million GBP
Released
Forecast
Spread
44,4
39,8
11%
52,9
45,2
17%
81,3
73,7
10%

94,1

119
Pre-Tax Profit (EBT)
Million GBP
Released
Forecast
Spread
25,8
25,1
2,8%
14,5
30,7
-53%
28,6
36,9
-23%

50,1

67,2
Net income
Million GBP
Released
Forecast
Spread
19,5
21,6
-10%
12,5
19,5
-36%
26,1
29,5
-12%

45,1

50,6
EPS
PNC
Released
Forecast
Spread
22,0
24,5
-10%
13,9
28,8
-52%
27,9
30,0
-7,0%

46,9

51,0
Announcement Date09/07/201509/05/201609/04/2017

Quarterly / Semiannualy publications
Previous yearPrevious periodNext periodNext Year
Quarterly resultsS1
2017
S2
2017
S1
2018
Sales
Million GBP
Released
Forecast
Spread
173
170
1,7%
187

194
193
0,75%
Operating income (EBITDA)
Million GBP
Released
Forecast
Spread




51,0
47,1
8,3%
Operating profit (EBIT)
Million GBP
Released
Forecast
Spread




47,4
43,6
8,6%
Pre-Tax Profit (EBT)
 GBP
Released
Forecast
Spread






Net income
Million GBP
Released
Forecast
Spread


13,4

26,9

EPS
PNC
Released
Forecast
Spread


14,3

28,7

Announcement Date02/27/201709/04/201702/26/2018

© 2018 Thomson Reuters
© 2018 Factset
Net sales (Year) - Rate of surprise
Operating profit (Year) - Rate of surprise
EPS (Year) - Rate of surprise